NCT06257953

Brief Summary

In recent years, obesity has become one of the leading health problems worldwide. It is known that obesity can cause various diseases and negatively impact the quality of life. Therefore, many conditions believed to be affected by obesity and relevant to patients\' quality of life have been scientifically investigated and continue to be researched. One of these conditions is postoperative pain, with studies in the literature indicating that postoperative pain levels increase in parallel with each unit increase in BMI. The incidence of lumbar disc herniation (LDH) is on the rise and adversely affecting the quality of life. The primary surgical intervention for LDH is discectomy. In recent years, various less invasive techniques, such as microdiscectomy, have been described to improve both surgical and analgesic outcomes. However, even with microdiscectomy surgery, postoperative pain may occur, and its control should be well-managed. Inadequate pain control can lead to unwanted effects of postoperative pain. Regional analgesia techniques may be preferred for effective analgesic treatment after spinal surgery. Methods such as paravertebral block, erector spinae plane block (ESPB), thoracolumbar interfascial plane block are widely used for analgesia in spinal surgery. The effectiveness of these regional techniques may vary depending on various factors, one of which is BMI. The hypothesis in this study is that as BMI increases, the level of pain in patients may also increase. As a result, this study aims to investigate the relationship between BMI and postoperative pain levels in patients undergoing standard LDH surgery, anesthesia, and analgesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2024

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

February 6, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 14, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2024

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 26, 2024

Completed
Last Updated

February 27, 2026

Status Verified

February 1, 2026

Enrollment Period

5 months

First QC Date

February 6, 2024

Last Update Submit

February 25, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain Scores

    Pain will be assessed at the first-hour rest and while coughing using the visual analog scale on a scale from 0 (no pain) to 10 (worst pain). Pain assessment will be done at the 1st hour after surgery.

    1st hour after surgery.

Secondary Outcomes (5)

  • Pain Scores

    2nd hour after surgery.

  • Pain Scores

    6th hour after surgery.

  • Pain Scores

    12th hour after surgery.

  • Pain Scores

    24th hour after surgery.

  • Intraoperative remifentanil consumption

    During the intraoperative period

Study Arms (3)

Patients with a BMI of 18-24.9 kg/m2

Following the visualization of the anatomical structures, the nerve block needle was advanced via the in-plane technique beneath the erector spinae muscles until the interfascial space was reached. After hydrodissection with 2 ml normal saline, 15 ml of 0.25% bupivacaine was injected into the area. Then the block process will be applied to the other side in the same way. A total of 30 ml of 15 ml 0.25% bupivacaine will be injected.

Procedure: Erector spinae plane block

Patients with a BMI of 25-29.9 kg/m2

Following the visualization of the anatomical structures, the nerve block needle was advanced via the in-plane technique beneath the erector spinae muscles until the interfascial space was reached. After hydrodissection with 2 ml normal saline, 15 ml of 0.25% bupivacaine was injected into the area. Then the block process will be applied to the other side in the same way. A total of 30 ml of 15 ml 0.25% bupivacaine will be injected.

Procedure: Erector spinae plane block

Patients with a BMI of 30-40 kg/m2

Following the visualization of the anatomical structures, the nerve block needle was advanced via the in-plane technique beneath the erector spinae muscles until the interfascial space was reached. After hydrodissection with 2 ml normal saline, 15 ml of 0.25% bupivacaine was injected into the area. Then the block process will be applied to the other side in the same way. A total of 30 ml of 15 ml 0.25% bupivacaine will be injected.

Procedure: Erector spinae plane block

Interventions

Erector spinae plane block will be applied to the patients under real-time ultrasound guidance.

Patients with a BMI of 18-24.9 kg/m2Patients with a BMI of 25-29.9 kg/m2Patients with a BMI of 30-40 kg/m2

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This prospective study includes adult patients aged 18 to 65 years with ASA physical status I-III who are scheduled to undergo elective LDH surgery under standardized general anesthesia and bilateral ESPB for postoperative analgesia at Ankara Etlik City Hospital. All participants meet predefined inclusion and exclusion criteria. Patients are categorized into three groups according to their preoperative BMI: 18-24.9 kg/m², 25-29.9 kg/m², and 30-40 kg/m². The study population represents consecutive eligible surgical patients during the study period. No experimental intervention beyond routine anesthetic and analgesic management is introduced; BMI serves as the exposure variable for comparative analysis of analgesic outcomes.

You may qualify if:

  • to 65 years old
  • ASA physical status I-II-III
  • BMI 18 to 40 kg/m²
  • Elective LDH surgery

You may not qualify if:

  • Patient refusing the procedure
  • Patients who have previously undergone spinal surgery
  • Chronic opioid or analgesic use
  • Patients who will operate under emergency conditions
  • Patients who will not undergo LDH surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Etlik City Hospital

Yenimahalle, Ankara, 06170, Turkey (Türkiye)

Location

MeSH Terms

Conditions

PainPain, PostoperativeAcute PainIntervertebral Disc Displacement

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic ProcessesSpinal DiseasesBone DiseasesMusculoskeletal DiseasesHerniaPathological Conditions, Anatomical

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal İnvestigator

Study Record Dates

First Submitted

February 6, 2024

First Posted

February 14, 2024

Study Start

January 10, 2024

Primary Completion

June 10, 2024

Study Completion

June 26, 2024

Last Updated

February 27, 2026

Record last verified: 2026-02

Locations